TrialAnnals of oncology : official journal of the European Society for Medical Oncology2017

Phase II randomized trial of carboplatin, paclitaxel, bevacizumab with or without cixutumumab (IMC-A12) in patients with advanced non-squamous, non-small-cell lung cancer: a trial of the ECOG-ACRIN Cancer Research Group (E3508).

A Argiris et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.